In the specialized field of biochemical research, the cRGDfK peptide stands out as a highly significant molecular tool. As someone deeply invested in the study of molecular interactions, I have found that the precision offered by this specific peptide is unparalleled for those investigating cell-surface dynamics. This article explores the structural pro It was found to bind specifically and with high affinity to αvβ3 receptors on neovascular blood vessel sections of different major human cancers. perties and research applications of this fascinating cyclic pentapept c(RGDfK) peptide ide c(RGDfK), which continues to be a cornerstone for laboratory-based investigations into cellular adhesion.
Understanding the cRGDfK Peptide Structure
The c(RGDfK) is a cyclic pentapeptide—specifically cyclo(Arg-Gly-Asp-D-Phe-Lys)—with a molecular weight of 603.7 g/mol. Its chemical structure of the synthet Cyclo(-RGDfK) TFA | Integrin inhibitor | CAS 500577-51-5 ic cyclic RGD peptide c(RGDfK) is optimized for high-affinity binding to specific integrin receptors. The inclusion of D-phenylalanine (f) within the ring structure provides the conformational rigidity necessary to mimic the natural binding motifs found in the extracellular matrix.
When comparing various research-grade compounds, I often look for the Cyclo(-RGDfK) TFA variant. The addition of trifluoroacetic acid (TFA) as a salt is a standard practice in the industry to enhance the stability and solubility of the cRGDfK for long-term storage and consistent performance in in-vitro assays.
Targeted Research Applications
One of the most compelling aspects of the Cyclic RGDFK peptide is its role as a selective ligand. My experience suggests that this molecule is a highly potent and selective inhibitor for the alphavβ3 integrin receptor. Because integrin receptors are often overexpressed in specific cellular environments, this peptide serves as an excellent probe for identifying and studying these receptors.
In advanced delivery studies, researchers have explored the cRGDfK pentapeptide as a targeting moiety. For example, the cRGDfK@GF-NLC (nanostructured lipid carriers) system has demonstrated how functionalizing a carrier with this peptide can improve the precision of reaching target sites. Whether you are working with a monomer, dimer, or tetramer of cyclic RGDfK peptides, the core RGD sequence remains the primary driver of its biological activity.
Key Insights for Laboratory Use
* Targeting Mechanism: Cyclo(-RGDfK) potently targets tumor microvasculatur by P Deepak · 2023 · Cited by 19 — The findings highlight cRGDfK@GF-NLC as a highly efficient carrier for targeted drug delivery, surpassing non-functionalized NLCs. e and cancer cells by binding to the cell surface, making it an essential reagent for those mapping the Arginylglycylaspartic acid-dependent pathways.
* Analytical Precision: Because c(RGDfK) is a cyclic peptide, it offers a higher resistance to enzymatic degradation compared to linear variants, ensuring that the i by RS Gamage · 2021 · Cited by 25 — Three cancer-targeting NIR fluorescent probes were synthesized, each with an appended cRGDfK peptide to provide selective affinity for integrin receptors. ntegrity of the Cyclic RGD peptide (cRGD) remains intact throughout the duration of an experiment.
* Experimental Scope: Whether you are using it for Cyclo(-RGDfK) radiolabeling or as a structural component for NIR fluorescent probes, the versatility of the cRGDfK molecule makes it a staple in contemporary molecular biology.
Conclusion
As a researcher, I find that the Cyclo(RGDfK) effectively targets tumor microvessels and cancer cells with a level of specificity that is difficult to achieve with less refined compounds. By adhering to strict laboratory protocols and utilizing high-purity cRGDfK, one can achieve reproducible results in characterizing the complex signaling landscapes governed by integrins. This peptide remains an indispensable asset for any serious investigation into the molec by S Liu · 2006 · Cited by 513 — Among several cyclic RGDfK peptides (monomer, dimer, and tetramer), E{E[c(RGDfK)]2}2 is the best targeting biomolecule with respect to its integrin αvβ3 binding ular mechanisms of cell adhesion and beyond.